<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: We studied whether increased urinary transferrin excretion rates (TERs) (urinary transferrin-to-urinary <z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio &gt; or = 107 micrograms/mmol, which is the sum of an average and 2 SDs in 431 healthy nondiabetic individuals) would predict the development of <z:mp ids='MP_0002959'>microalbuminuria</z:mp> (urinary albumin-to-urinary <z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio &gt; or = 2.8 mg/mmol) in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:mpath ids='MPATH_458'>normal</z:mpath> urinary albumin excretion rates (AERs) (albumin-to-<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio &lt; 2.8 mg/mmol) </plain></SENT>
<SENT sid="1" pm="."><plain>We also studied the influence of blood pressure, glycemic control, and serum levels of <z:chebi fb="23" ids="18059">lipids</z:chebi> and <z:chebi fb="0" ids="39015">apolipoproteins</z:chebi> on the later development of <z:mp ids='MP_0002959'>microalbuminuria</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: In 77 diabetic patients with <z:mpath ids='MPATH_458'>normal</z:mpath> AER, AER and TER were measured at baseline and after 24 months of follow-up </plain></SENT>
<SENT sid="3" pm="."><plain>Blood pressure, glycemic control, and serum levels of <z:chebi fb="23" ids="18059">lipids</z:chebi> and <z:chebi fb="0" ids="39015">apolipoproteins</z:chebi> were measured at 1- to 2-month intervals during the follow-up period </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Of the 16 patients who initially had increased TER, 5 (31%) developed <z:mp ids='MP_0002959'>microalbuminuria</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, of the 61 who initially had <z:mpath ids='MPATH_458'>normal</z:mpath> TER, 4 (7%) developed <z:mp ids='MP_0002959'>microalbuminuria</z:mp> (P = 0.016) </plain></SENT>
<SENT sid="6" pm="."><plain>At baseline, no difference was found in age, sex, <z:mp ids='MP_0002055'>diabetes</z:mp> duration, diabetic medications, prevalence of <z:hpo ids='HP_0000822'>hypertension</z:hpo>, blood pressure, HbA1c levels, or serum <z:chebi fb="23" ids="18059">lipid</z:chebi> and <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> concentrations between the two group of patients with <z:mpath ids='MPATH_458'>normal</z:mpath> and increased TER </plain></SENT>
<SENT sid="7" pm="."><plain>There was also no difference in duration of <z:hpo ids='HP_0000822'>hypertension</z:hpo> and prevalence of users of <z:chebi fb="2" ids="35457">ACE inhibitors</z:chebi> between two subgroups of hypertensive patients with <z:mpath ids='MPATH_458'>normal</z:mpath> and increased TER </plain></SENT>
<SENT sid="8" pm="."><plain>During the 24 month follow-up period, those whose condition progressed to <z:mp ids='MP_0002959'>microalbuminuria</z:mp> had increased serum levels of <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (1.87 +/- 0.49 vs. 1.29 +/- 0.64 mmol/l, P = 0.003) and <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> B (114 +/- 20 vs. 102 +/- 24 mg/dl, P = 0.05) and tended to have <z:mp ids='MP_0006353'>increased HbA1c levels</z:mp> (7.7 +/- 1.0 vs. 7.1 +/- 1.1%, P = 0.10) compared with those in whom <z:mp ids='MP_0002959'>microalbuminuria</z:mp> did not develop </plain></SENT>
<SENT sid="9" pm="."><plain>Blood pressure, however, did not differ </plain></SENT>
<SENT sid="10" pm="."><plain>In multivariate stepwise logistic regression analysis, the association between increased TER at baseline and subsequent development of <z:mp ids='MP_0002959'>microalbuminuria</z:mp> was significant (odds ratio 7.04 [95% CI 1.02-48.5], P = 0.04) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: In patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:mpath ids='MPATH_458'>normal</z:mpath> AER, increased TER may predict the development of <z:mp ids='MP_0002959'>microalbuminuria</z:mp> and abnormalities in <z:chebi fb="0" ids="17855">triglyceride</z:chebi>-rich <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> metabolism, and poor glycemic control may be associated with this progression </plain></SENT>
</text></document>